Search | Cryell

Pratiksha Dhote added blog Health
2025-12-02 12:22:19 -

Beyond CRISPR: Exploring the Commercial Potential of Base Editing and Prime Editing Technologies in the Gene Editing Market
The Gene Editing Market continues to depend heavily on foundational research to overcome key technological limitations, most notably the challenge of off-target editing and the need for optimized delivery systems. Off-target editing—unintended changes to the genome at sites other than the desired location—remains a major safety concern that could lead to unforeseen health...

0 Comments 0 Shares 171 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Health
2025-12-18 11:05:15 -

Gene Editing for Rare Diseases: The "N-of-1" Revolution in 2025
In 2025, the medical community has finally addressed a long-standing tragedy: the thousands of rare diseases that were too niche for pharmaceutical companies to notice. Thanks to gene editing, we have entered the era of "N-of-1" medicine, where a therapy can be designed and manufactured for a single individual with a unique genetic mutation. By using a "modular" CRISPR platform, scientists can...

0 Comments 0 Shares 3 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Health
2025-12-19 12:32:22 -

Growth of Veterinary Industry Segments Using Genomic Alteration in Livestock
The veterinary industry segments are exploring the use of genomic alteration to improve the health and productivity of livestock. Use cases include developing pigs that are resistant to devastating respiratory diseases and cattle that produce less methane. These interventions are not only better for the welfare of the animals but also contribute to the sustainability of the global food system....

0 Comments 0 Shares 3 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Health
2025-12-19 13:48:40 -

Next-Generation CRISPR and the Rapid Expansion of the Global Gene Editing Sector
The biological landscape is shifting toward precision medicine at an unprecedented pace. The emergence of CRISPR-Cas9, ZFNs, and TALENs has revolutionized how researchers approach genetic disorders. By allowing scientists to rewrite the code of life with surgical accuracy, these tools are no longer confined to theoretical research but are actively being applied to treat sickle cell anemia and...

0 Comments 0 Shares 2 Views 0 Reviews

Please log in to like, share and comment!